Nourish, a virtual nutrition care platform, has closed a $70 million Series B round to accelerate product development, expand its network of Registered Dietitians, grow its team and strengthen partnerships.
The round—bringing Nourish’s total funding to $115 million—was led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Thrive Capital, Index Ventures, Y Combinator, Maverick Ventures, BoxGroup, Atomico, G Squared and Pinegrove.
The funding comes at a time of growing dissatisfaction with the traditional healthcare system and a broader shift toward preventative care.
Founded just over three years ago on the principle of “food as medicine,” Nourish connects patients, dietitians, and insurance payers to provide insurance-covered nutritional care for diet-related conditions—where 94% of patients pay $0 out of pocket. The platform now serves hundreds of thousands of patients and employs more than 3,000 Registered Dietitians.
“We built Nourish to make healthcare radically better for millions of Americans — it’s the care we wanted ourselves during our own patient journeys,” Nourish co-founder and CEO Aidan Dewar said. “We wanted to build a patient-friendly healthcare system with lifestyle change and nutrition as a first-line treatment, not an afterthought. We’re combining cutting-edge AI with the best RD team in the country to deliver personalized care that actually works at a fraction of the cost of traditional medicine. It is not only more effective and accessible but also more human.”
The platform’s app features AI meal tracking, recipes and offers wearable and lab integrations for patients. On the RD side, it offers an “AI copilot” that automates note-taking and assists with clinical insights.
In addition to improvements in clinical markers like A1C and LDL, recently published data from Nourish shows that patients using GLP-1 medications such as Ozempic lost 33% more weight when paired with a Nourish Registered Dietitian. The patients also demonstrated better medication adherence and experienced fewer side effects.
“Our healthcare system is at an inflection point, with chronic disease rates and costs rising to unsustainable levels,” Nourish co-founder, president and chief operating officer Sam Perkins said. “Payers are under growing pressure to find scalable solutions that actually work. Nourish meets this need by addressing the root cause of chronic disease — giving payers a powerful new lever to improve outcomes, bend the cost curve and deliver a care experience members love.”
